Abstract. The Apaf-1 interacting protein (APIP) and the uveal autoantigen with coiled coil domains and ankyrin repeats (UACA) belong to endogenous regulators of the apoptosome apparatus, but their role in tumourigenesis and progression of non-small cell lung carcinoma (NSCLC) is not known. Previous studies demonstrated that APIP inhibits the apoptosome-mediated procaspase-9 activation while UACA induces translocation of Apaf-1 from the cytoplasm into the nucleus. Here, we report for the first time that the expression of APIP and UACA genes is down-regulated on the level of both mRNA and protein in NSCLC cells and tumours. In particular, the expression of APIP protein was strikingly decreased and the expression of UACA mRNA and protein was frequently down-regulated in NSCLC tumours of different histopathological types. Moreover, stage IA NSCLC tumours showed significantly lower expression of UACA mRNA compared to higher stage tumours. The weak increase of both APIP and UACA mRNA levels in the 5-aza-2'-deoxycytidine-treated NSCLC cells indicates that mechanisms other than DNA methylation are involved in the regulation of APIP and UACA gene expression in these cancer cells. Taken together, the down-regulation of APIP and UACA expression suggests that the threshold to activate the apoptosome apparatus may be decreased in NSCLC cells due to the lack of APIP-mediated suppression and UACA-assisted Apaf-1 nuclear entry. Moreover, the loss of UACA-assisted Apaf-1 nuclear translocation may underlie the failure of DNA damage checkpoint activation in NSCLC cells leading to their genomic instability.
IntroductionThe apoptosome apparatus is a stress-induced cell death signalling platform that is assembled in the cytosol via the cytochrome-c (cyt-c)-and (d)ATP-mediated formation of an Apaf-1 heptameric complex, which recruits and activates the apoptosis initiator procaspase-9 (PC-9) (1-3). Both epigenetic and transcriptional factor-mediated regulation of Apaf-1 and PC-9 expression levels plays an important role in predisposition of cells to activate the apoptosome apparatus (4-8). However, the processes of apoptosome assembly and functioning in cancer cells are under a variety of negative and positive modes of post-translational regulation (9,10). There is evidence that the hypersensitivity of certain malignant neoplasms such as brain tumours and breast carcinomas, as opposed to their normal tissue counterparts, to the cyt-c-induced apoptosis is due to up-regulation of Apaf-1 and its regulator PHAPI, respectively, in cancer cells (11,12). On the other hand, deficient signalling in the apoptosome pathway, due to the lack of apoptosome core component expression or apoptosome dysfunction, contributes to tumourigenesis and progression of malignant neoplasms as well as to their chemo-and radioresistance (8,(13)(14)(15)(16)(17)(18)(19)(20).The activation of apoptosome apparatus is often impaired in non-small cell lung carcinoma (NSCLC) cells and tissues (21,22). The molecular basis of apoptosome apparatus suppression in NSCLC is sti...